WFH/LinkedIn
Sep 18, 2025, 09:18
WFH Vice President Glenn Pierce on Slow Uptake and Industry Shifts in Hemophilia Gene Therapy
The World Federation of Hemophilia (WFH) posted on LinkedIn:
”WFH Vice President, Medical, Glenn Pierce, joins Zoey Becker in this week’s episode of The Top Line, to unpack the complex reality of Gene Therapy for hemophilia. Pierce discusses why the uptake remains slow, what led to some pharma companies exit and who risks being left behind in this evolving landscape.
Listen now.”
Stay updated with Hemostasis Today.
-
Feb 18, 2026, 12:41Davide Bartoli: The Hidden Cost of Informal Caregiving After Stroke
-
Feb 18, 2026, 12:34Amy Goundry: Which Are The Next Major Advances in Blood and Plasma-Driven Immune Regulation?
-
Feb 18, 2026, 12:26John Monczewski: A Stroke, A Wake‑Up Call, And a Whole Lot of Gratitude
-
Feb 18, 2026, 12:15Danny Hsu: Are Elastic Compression Stockings Ineffective in Preventing Post-Thrombotic Syndrome?
-
Feb 18, 2026, 11:49David Hunt: The Critical Importance of Stroke Awareness
-
Feb 18, 2026, 11:35University of Minnesota Physicians: Christopher Streib Builds A Telestroke Program for Rural Areas in Minnesota
-
Feb 18, 2026, 11:22Michelle Rosenfeld: Mobile Stroke Units in the MENA Region Show How Fast Can Stroke Care Be
-
Feb 18, 2026, 11:15Bader Almohaimeed: Insights On Advancing Stroke Systems of Care
-
Feb 18, 2026, 11:09Sophie Rex Christensen: A Milestone That Brings Us Closer to Earlier, Non-Invasive Stroke Detection